Loading
Life sciences · Interventional Study
ClinicalTrials.gov · September 25, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Interventional Study.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Registry record from ClinicalTrials.gov (NCT05913713). This is a study registration, not published results. Lead sponsor: University of Florida. Recruitment status: COMPLETED. Phase: NA. Study type: INTERVENTIONAL. Enrollment: 37 participants (ACTUAL). Conditions: Breast Cancer. Interventions: BEHAVIORAL: 12-week Intervention Period; BEHAVIORAL: 12-week Observation Period. Primary outcome measures: Change in brachial FMD , Baseline, Following a 12-week intervention period, Following a 12-week observation period; Change in cardiac function (global longitudinal strain) , Baseline, Following a 12-week intervention period, Following a 12-week observation period; Percent completed vs. planned exercise frequency , Throughout the 12 weeks of supervised home-based exercise training; Percent completed vs. planned exercise duration , Throughout the 12 weeks of supervised home-based exercise training; Percent completed vs. planned exercise intensity , Throughout the 12 weeks of supervised home-based exercise training; Number of participants who experience adverse events as defined by most recent CTCAE throughout the exercise intervention , Throughout the 12 weeks of supervised home-based exercise training. Brief summary: Chemotherapy is an effective breast cancer treatment, which helped to increase the 5-year survival rate to approximately 95%. However, breast cancer survivors have a higher risk of cardiovascular disease (CVD) due to chemotherapy than adults without cancer. Cardiovascular rehabilitation can be an effective strategy to decrease the incidence of CVD and its risk factors in this population. The proposed study may help to examine the effect and durability of a novel high-intensity interval training compared to moderate-intensity continuous training on cardiovascular rehabilitation in breast cancer survivors.